Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).

Surasak SaokaewShada KanchanasuwanPiyaporn ApisarnthanarakAphinya CharoensakPhunchai CharatcharoenwitthayaPochamana Phisalprapa Nathorn Chaiyakunapruk

Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)

A simple and non-invasive scoring scheme of five predictors provides good prediction indices for NAFLD in MetS patients. This scheme may help clinicians in order to take further appropriate action.

Keyphrases

end stage renal disease
metabolic syndrome
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
mass spectrometry
type diabetes
cardiovascular disease
adipose tissue
patient reported outcomes